Alzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway. (Q48728006)

15 February 2018

title

Alzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway. (English)

1 reference

15 February 2018

0 references

3

1 reference

15 February 2018

C F Lippa

series ordinal

1

object named as

C F Lippa

1 reference

15 February 2018

D Pulaski-Salo

series ordinal

2

object named as

D Pulaski-Salo

1 reference

15 February 2018

T W Smith

series ordinal

4

object named as

T W Smith

1 reference

15 February 2018

publication date

1 April 1997

1 reference

15 February 2018

Journal of the Neurological Sciences

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 February 2018

volume

147

1 reference

15 February 2018

issue

2

1 reference

15 February 2018

page(s)

161-166

1 reference

15 February 2018

Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

A pathological study of the association between Lewy body disease and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Identification of normal and pathological aging in prospectively studied nondemented elderly humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Apolipoprotein E genotype and Lewy body disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Detection of Lewy bodies in Trisomy 21 (Down's syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Perforant pathway changes and the memory impairment of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Some morphometric aspects of the brain in senile dementia of the alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Cell loss in the locus coeruleus in senile dementia of Alzheimer type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Entorhinal cortex pathology in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Synaptic loss in Alzheimer's disease and other dementias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Staging of Alzheimer's disease-related neurofibrillary changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Apolipoprotein E genotyping by one-stage PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Some new, simple and efficient stereological methods and their use in pathological research and diagnosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Is hippocampal cell death a myth?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Diffuse Lewy body disease: clinical features in 15 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Antemortem diagnosis of diffuse Lewy body disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

Cell loss from the nucleus basalis of Meynert in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Operational criteria for senile dementia of Lewy body type (SDLT)

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905321-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(96)05321-X

1 reference

15 February 2018

PubMed ID

9106122

1 reference

15 February 2018